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Circle of support
Each loop of crocheted yarn is interdependent on another; miss a
loop or fray it and the structure becomes unstable. Stroke survivor
Lindsay Obermeyer came to appreciate her dependence on
caregivers, family and friends. The artist, treated at the Washington
University and Barnes-Jewish Stroke & Cerebrovascular Center,
became fascinated with the research of Amar Dhand, MD, DPhil,
who studies social networks and stroke outcomes. The two began
collaborating on ways to artistically visualize the support networks
of stroke patients. Obermeyer plans an installation that will include
1,600 crocheted images, the number of stroke patients treated
annually at Barnes-Jewish Hospital.
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Designed around the concept of
“neighborhoods,” the research building at
4515 McKinley opens it doors, ushering in
a new era of collaborative science.
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A lab is using 3-D printing to create prosthetic
limbs for pediatric patients and an assortment
of anatomical models and training tools for
physicians and researchers.
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manager partner together to make commercial
construction workers safer.
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A single test
for a world of
viruses
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Living without full use of her
hands is normal for Olivia, who developed a
rare autoimmune disease as a baby. Researchers
recently made Olivia, now almost 5, a powderyblue mechanical prosthesis decorated with
dinosaurs and her name in cursive. 3-D printing
allows researchers to customize raw materials
to meet specific health needs and, in the
process, is heralding a new direction in patient
care. See page 10.
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Understanding the preemie brain
Increased risk of neurological and psychiatric issues calls for earlier intervention

B

abies born prematurely face an
increased risk of neurological
and psychiatric problems that
may be due to weakened connections
in brain networks, new research shows.
Studying brain scans from premature
and full-term babies, School of Medicine
researchers zeroed in on differences in the
brain that may underlie such problems.
“The brain is particularly ‘plastic’ very
early in life and potentially could be modified by early intervention,” said principal
investigator Cynthia E. Rogers, MD, assistant
professor of child psychiatry. “We usually
can’t begin interventions until after symptoms develop, but what we’re trying to do
is develop objective measures of brain
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development in preemies that can indicate
whether a child is likely to have later
problems so that we can intervene with
extra support and therapy early on to try
to improve outcomes.”
One of every nine infants in the U.S. is
born early and, thus, with increased risk of
cognitive difficulties, problems with motor
skills, attention deficit-hyperactivity disorder, autism spectrum disorders and anxiety.
Rogers, along with senior author
Christopher D. Smyser, MD, assistant professor of pediatric neurology, and colleagues
in the Washington University Neonatal
Development Research Lab, used functional
magnetic resonance imaging and diffusion
tensor brain imaging to compare 58 babies
born at full term with 76 infants born at
least 10 weeks early.

The researchers found that some key
brain networks — those involved in
attention, communication and emotion —
were weaker in premature infants.
“We found significant differences in
the white matter tracts and abnormalities
in brain circuits in the infants born early,
compared with those of infants born at
full term,” said Rogers, who treats patients
at St. Louis Children’s Hospital.
Scans show differences in preemies’
resting-state brain networks, particularly
in a pair of networks previously implicated
in learning and developmental problems.
Rogers said these brain circuit abnormalities likely contribute to problems
that materialize as the children get older.
The researchers are continuing to follow
the children as they develop over time.
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St. Louis College of Pharmacy and the School of Medicine
are joining forces to find better, safer and more effective
ways to use prescription medications to improve health.
Researchers from the two institutions are collaborating
to create the Center for Clinical Pharmacology.
Initial focus will be on translational and clinical
research to better understand and improve pain treatment. The new center will concentrate on how to best
use existing drugs to treat pain, as well as on developing
and identifying new analgesic drugs and other therapeutic approaches for pain.
About 100 million American adults are affected by
chronic pain, more than the total affected by heart
disease, cancer and diabetes combined. Tailoring treatments to individual patients is one of the center’s goals.
“This collaborative venture between the academic
institutions of pharmacy and medicine is unique in the
field of clinical pharmacology and a major strength,”
said new center director Evan D. Kharasch, MD, PhD,
the Russell D. and Mary B. Shelden Professor of
Anesthesiology and professor
of biochemistry and molecular
biophysics at the School of
Medicine. “Combining the
expertise of both institutions
will allow us to develop and
deliver on the promises of
precision medicine and find
the most effective ways to
treat individual patients.”
Researchers also will try
St. Louis College of Pharmacy
to prevent some of the abuse
problems associated with pain medications. Prescription
opioid analgesics play a role in 17,000 deaths every year
in the U.S. Studies estimate that societal costs are more
than $70 billion annually, including health-care costs,
costs for lost productivity in the workplace and costs in
the criminal justice system. Dependence on opioid painkillers can become a gateway to heroin and other drugs
of abuse, Kharasch said.
Also joining the center as co-director is Karen Seibert,
PhD. Seibert is a professor of pathology and immunology and of genetics, director of Genomics and Pathology
Services and associate director of shared services at
the Siteman Cancer Center.
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Pharmacy partnership
seeking better meds

WHEN I’M 64 Today’s freshmen have a 50 percent chance
of living to see their 100th birthdays. A new course, “When
I’m 64,” gives Washington University undergraduates a taste of
the physical and mental challenges associated with aging. It is
co-taught by Susy Stark, PhD, assistant professor of occupational
therapy, and faculty in psychology and social work. The goal
is to build understanding and highlight career opportunities
in working with older people.

Bhayani named chief medical officer
of Washington University Physicians
Sam B. Bhayani, MD, has been appointed chief medical
officer (CMO) of the Faculty Practice Plan.
In this newly created position, Bhayani will work
closely with James P. Crane, MD, associate vice chancellor
for clinical affairs and chief executive officer of
the Faculty Practice Plan. The plan,
known as Washington University
Physicians, ranks among the five largest
academic group practices in the U.S.
As CMO, he will work with the
medical schools’s clinical departments
to ensure that services and programs
are “best in class” in terms of clinical
quality, patient outcomes, patient safety
and patient satisfaction.
In partnership with BJC HealthCare, Sam Bhayani, MD
Bhayani also will help design and implement the new,
unified electronic patient medical record system. Further,
he will facilitate the development of strategies and payment
models focused on population health management and
value-based health care, and will work with Crane to
coordinate and communicate with BJC on systemwide
initiatives that affect the plan.
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Why parasite makes
TB infections worse
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GOING GREEN First-year medical students volunteered
at St. Louis-area gardens to see how community-building
efforts can improve patients’ health. City Seeds Urban
Farm (above) is part of Gateway Greening, a non-profit
organization working to sustain green spaces and address
urban problems such as limited access to fresh produce.

Silverman named head of pediatrics
Gary A. Silverman, MD, PhD, has been named
the Harriet B. Spoehrer Professor and head of the
Department of Pediatrics. With the new appointment,
effective in April, Silverman will become pediatricianin-chief at St. Louis Children’s Hospital and executive
director of the Children’s Discovery Institute, a partnership of the school and hospital.
A highly regarded neonatologist,
Silverman comes from the University
of Pittsburgh School of Medicine,
where he is vice chair for basic
research in the school’s Department
of Pediatrics and at Children’s
Hospital of Pittsburgh. He also is
the Twenty-Five Club Professor
of Pediatrics, Cell Biology and
Gary Silverman, MD, PhD Physiology at the medical school
and division chief of newborn medicine at Children’s
Hospital of Pittsburgh and Magee-Womens Hospital.
Both hospitals are part of the University of Pittsburgh
Medical Center.
Silverman succeeds Alan L. Schwartz, PhD, MD,
who has led the department since 1995. Schwartz will
remain on the faculty and devote more time to national
leadership commitments, mentoring faculty and trainees,
Enjoy interactive elements and added content
and to his research.
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Scientists have shown how a parasitic worm infection
common in the developing world increases susceptibility to tuberculosis. The study demonstrated that treating for
parasites reduces lung damage seen in mice that also are
infected with tuberculosis, thereby eliminating the vulnerability to tuberculosis (TB) that the parasite is known to cause.
The study raises the possibility of using inexpensive
and widely available anti-parasitic drugs as a preventive
measure in places where the parasite and TB are common
— stopping infection with the parasite and reducing
susceptibility to TB and the risk of a latent TB infection
progressing to disease. The research appears in The Journal
of Clinical Investigation.
“Scientists and doctors have known that having both
infections — this parasitic worm and tuberculosis — results
in increased susceptibility to severe lung disease than having
TB alone,” said Shabaana A. Khader, PhD, associate professor of molecular microbiology. “But if we don’t understand
why co-infection increases the susceptibility to TB, it is difficult to know how to deal with the situation.” Public health
experts estimate that onethird of the world’s population is infected with TB.
Most of these infections
are not active and cause no
symptoms because individuals’ immune systems
are effective at containing
them. According to the
researchers, people with
latent tuberculosis infections have a 10 percent
lifetime risk of developing Parasitic worms linked with TB
active TB. And that risk
may go up when people are infected with a type of
parasitic worm called helminths, which are common in
parts of the world where TB is also prevalent.
Khader said that scientists have suspected that the parasitic infection has some way of blocking the protective
immune response needed to keep TB in check. But Khader
and her colleagues found that something else is going on.
“We showed that the parasite activates a type of immune
cell that drives inflammation rather than inhibiting the
immune response that protects against active TB,” Khader
said. “If you treat the parasite alone in these mice that
also have TB, you go back to having the good immunity
against TB.”
Winter 2015–16

SELFIE SMILES Michael Awad, MD, PhD, associate dean for medical education,
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takes a selfie with first-year medical students during the White Coat Ceremony.
Decked out in the symbol of their chosen profession, the 123 newly minted medical
students recited the oath they wrote promising honesty and integrity.

Drug trio beats deadly infection

T

hree antibiotics that, individually,
are not effective against a drugresistant staph infection can kill
the deadly pathogen when combined as a
trio, according to new research.
The researchers have killed the bug —
methicillin-resistant Staphylococcus aureus
(MRSA) — in test tubes and laboratory
mice, and believe the same three-drug
strategy may work in people.
“MRSA infections kill 11,000 people
each year in the United States, and the
pathogen is considered one of the world’s
worst drug-resistant microbes,” said principal investigator Gautam Dantas, PhD,
an associate professor of pathology and
immunology. “Using the drug combination
to treat people has the potential to begin
quickly because all three antibiotics are
approved by the FDA.”
The drugs — meropenem, piperacillin and tazobactam — are from a class of
antibiotics called beta-lactams that has not
been effective against MRSA for decades.

outlook.wustl.edu

Working with collaborators in the
microbiology laboratory at Barnes-Jewish
Hospital, Dantas’ team tested and genetically analyzed 73 different variants of the
MRSA microbe to represent a range of
hospital- and community-acquired forms
of the pathogen. The researchers treated
the MRSA bugs with the drug combination
and found that it worked in every case.
Then, in experiments conducted by collaborators at the University of Notre Dame,
the team found that the drug combination
cured MRSA-infected mice and was as
effective against the pathogen as one of
the strongest antibiotics on the market.
“Without treatment, these MRSAinfected mice tend to live less than a day,
but the three-drug combination cured the
mice,” Dantas said. “After the treatment,
the mice were thriving.”
Dantas explained that the drugs, which
attack the cell wall of bacteria, work in a
synergistic manner, meaning they are more
effective combined than each alone.

Piperacillin and tazobactam (bottle on left) and
meropenem — more effective when used together
The researchers also found that the
drugs didn’t produce resistance in MRSA
bacteria — an important finding since
more and more bacteria are developing
resistance to available drugs.
The team is investigating other antibiotics thought to be ineffective against various
bacterial pathogens to see if they, too, may
work in combination with other drugs.
“We started with MRSA because it’s
such a difficult bug to treat,” he said.
“But we are optimistic the same type of
approach may work against other deadly
pathogens, such as Pseudomonas and
certain virulent forms of E. coli.”

Outlook 5
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Painkiller abusers use
cheap, available heroin
TEAM SPIRIT Once a Cardinal, always a Cardinal.
David H. Perlmutter, MD (left), has returned to St. Louis to
take over as executive vice chancellor for medical affairs and
dean of the School of Medicine. His tenure began Dec. 1.
A former Washington University faculty member, Perlmutter
succeeds Larry J. Shapiro, MD, who stepped down after
leading the medical school for 12 years. Shapiro will
continue working at the medical school as the Spencer T.
and Ann W. Olin Distinguished University Professor.

National Academy of Medicine
elects Wahl as member
Richard L. Wahl, MD, the Elizabeth E. Mallinckrodt
Professor and head of radiology, has been elected to
the National Academy of Medicine, formerly known as
the Institute of Medicine. Election is considered one of
the highest honors in the field of health and medicine
in the U.S.
Wahl, also director of the Mallinckrodt Institute of
Radiology, was among the first to combine internally
delivered radiation therapy for nonHodgkin’s lymphoma with techniques
that use the immune system and
nuclear medicine imaging to inform
and precisely target treatments.
The combined approach, now FDAapproved, is known as radioimmunotherapy and is considered one of the
first “precision medicine” approaches
Richard Wahl, MD
in human cancer treatment.
He has been a leader in introducing and using positron
emission tomography (PET) to diagnose a broad array
of cancers and other diseases.
Wahl also is at the forefront of efforts to combine
quantitative data from PET scans with CT and MRI to
Enjoy interactive elements and added content
form “fusion” images that can help physicians more
precisely diagnose and characterize cancers.
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Drug abusers are not completely abandoning prescription
opioids for heroin. Instead, many use the two concurrently
based on their availability, according to a survey of 15,000
patients at drug-treatment centers in 49 states.
The findings also reveal regional variations in the use of
heroin and prescription painkillers. “On the East and West
coasts, combined heroin and prescription drug use has surpassed the exclusive use of prescription opioids,” said senior
investigator Theodore J. Cicero, PhD. “This trend is less
apparent in the Midwest, and in the Deep South, we saw a
persistent use of prescription drugs — but not much heroin.”
Across the country in 2014, almost 42 percent of drug
users in treatment reported they had taken heroin and prescription painkillers within a month of entering treatment,
up from 23.6 percent in 2008, the researchers found. “We
see very few people transition completely from prescription opioids to heroin; rather, they use both drugs,” he said.
“There’s not a total transition to heroin, I think, because of
concerns about becoming a stereotypical drug addict.”
A professor of
neuropharmacology in
psychiatry, Cicero said
that although heroin
has spread beyond
inner cities into suburban and rural areas,
many users still associate the drug with
junkies they’ve seen
depicted in movies
and on television.
“People used to tell us quite often, ‘At least I’m not using
heroin,’ when we asked about their drug abuse,” Cicero said.
“But in recent years, many have come to ignore that aversion,
both because heroin is cheaper and accessible and because
they’ve seen friends and neighbors use heroin.”
Cicero’s team conducted anonymous surveys when
users entered drug treatment, asking about drugs of choice
and patterns of use and abuse. Survey takers also had the
option of giving up their anonymity to answer more detailed
questions about their drug use. The study included detailed
data from 267 such patients. Of them, 129 reported they
had abused prescription opioids prior to heroin, and 73
percent cited factors such as cost and accessibility when
explaining why they began using heroin.
The federal government’s push to shut down “pill mills”
and doctors illegally prescribing painkillers has made it
harder to get prescription painkillers, Cicero said.
Winter 2015–16
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move
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Opening of research
facility signals new era
in collaborative science
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4 515 M c K I N L E Y

A

new building dedicated to interdisciplinary
research on some of the most complex problems
in human biology is now open on the Medical
Campus. The collaborative, state-of-the-art environment
will support rapidly changing scientific techniques and
the explosive advancement of genetics and genomics.
The six-story facility brings together groups of
investigators and adds 138,000 square feet of highly
flexible, open labs.
Designed for LEED Silver certification, the $81.1-million
building replaces some of the older, less efficient research
lab spaces. Built for investigator comfort, labs in the
building conveniently are located adjacent to office space,
separated only by glass walls. This gives researchers the
flexibility to step away, take notes, make journal entries,
or even have a snack, while still monitoring activities on
the bench. Communal spaces, like conference rooms,
kitchens and break areas, are centralized and
easily accessible.
To encourage cross-disciplinary dialogue, the design
also incorporates “neighborhoods” on each floor —
where researchers working on dissimilar projects might
be gathered into smaller clusters. In one large lab, for
example, researchers studying male infertility will work
alongside scientists investigating autism and others
studying diabetes and metabolism, all in mice.
Researchers making the move include those from:
the Department of Genetics; the Center for Genome
Sciences & Systems Biology; the Division of Oncology in
the Department of Medicine; the Center for Regenerative
Medicine in the Department of Developmental Biology;
and Mallinckrodt Institute of Radiology’s (MIR) Optical
Radiology Lab and Molecular Imaging Center. Until now,
the 16 faculty members in the genetics department
have been working in six different locations.
The building will house two new centers:

ERIC YOUNG

Central stairwell

8 Washington University School of Medicine

The Center for Cellular Imaging, established by the
departments of Anatomy and Neurobiology and of Cell
Biology & Physiology, will serve as a shared technology
resource for the medical school community. The center
will facilitate the use of multi-scale cellular imaging
technologies to investigate, at unprecedented resolution,
the 3-D structure and dynamic behavior of biological
systems.
Winter 2015–16
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The Center for Multiple Myeloma Nanotherapy,
also part of MIR, will develop therapies for multiple
myeloma, a cancer of immune cells in bone marrow.
The National Cancer Institute awarded $13.7 million
in research support.

1

2

1 Work /study carrels adjoin labs
2 Collaborative social spaces
3 Benches ready for research
4 Central corridors connect all spaces
5 Microscopy lab setup
6 Unpacking boxes upon boxes
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Need a custom
yet affordable
anatomical structure
made to order?
Just hit print.

D E TA C H E D P R O S T H E T I C L I M B S in pink
and blue add flare to a colorless scene of Bunsen burners
and beakers, microscopes and magnifiers, computers
and chemicals sprawling inside the Minimally Invasive
Surgery (MIS) Biomaterials Laboratory at Washington
University School of Medicine.
But the lab’s superstar — a desktop 3-D printer —
appears nondescript, a big black box of a wallflower, a
device resembling a microwave both in its appearance
and in its revolutionary potential to transform an
industry. The powerhouse prints
three-dimensional body parts,
including the prosthetic hands
and arms in bubble-gum pink
and baby-boy blue. The tool allows
researchers to shape raw materials
to meet specific health needs and,
in the process, is heralding a new
direction in patient care.
Globally, the medical industry
is experimenting with 3-D printers to treat patients,
tailor-making everything from skull fragments to fingers
and teeth to heart valves and stents. Scientists, including
those at the School of Medicine, also have ventured
into the field of regenerative medicine by printing
structures from living cells instead of inorganic
materials. The ultimate goal in the medical field is
to print a patient’s own cells, for instance, to regrow
complex nerves after an injury or to create implantable
organs for transplant patients that could eliminate
waiting lists and organ rejection.

Lending
a hand

BY KRISTINA SAUERWEIN

10 Washington University School of Medicine

Winter 2015–16

JERRY NAUNHEIM

Not-quite-5-year-old
Olivia repays her priceless
gift with a hug for
biomedical engineering
student Savannah Est,
a member of the research
team that designed and
fabricated Olivia’s new
mechanical hand.
outlook.wustl.edu
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At the MIS lab, physicians, scientists and
engineering students have carved a niche in 3-D
printing: Producing prosthetic arms and hands
for children who have lost limbs due to disease or
accidental injury. The team’s efforts have attracted
a lot of media attention since pediatric patients
typically are poor candidates for traditional prostheses, mainly because fitted prostheses can cost
tens of thousands of dollars and need frequent
resizing and replacement to keep pace with a
child’s growth. By comparison, materials for a 3-D
printed prosthesis can cost a few hundred dollars.
“The possibilities with 3-D printing in health
care have the power to revolutionize medicine,”
said Charles Goldfarb, MD, chief of orthopedic
surgery at St. Louis Children’s Hospital, who
works closely with patients to determine eligibility
for prostheses. “It’s exciting.”

TIM PARKER
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ydney Kendall received a pink robotic
arm seven years after she lost her
right arm, just below the elbow, in
an accident involving a jet ski, boat
and rampant rope at the Lake of the
Ozarks in central Missouri. Sydney, who lives in
suburban St. Louis, was 6 years old at the time,
in kindergarten, and, after having just mastered
how to print her name, had to re-learn how to
write with her left hand. The stares, pointing,
awkward and sometimes rude comments thickened her skin during a life stage often marked
by innate innocence.
The robotic arm, humorously named “Pinky,”
arrived with fanfare during Sydney’s last year of
middle school, in May 2014, when she was 13
and in the eighth grade. Powered by a nine-volt
battery, the pink prosthesis used a microchip
and motion-detecting sensor on Sydney’s shoulder
to activate fingers, including independent thumb
movement, restoring her ability to throw a ball
or move a computer mouse with her right limb.
News media big and small spotlighted Sydney
and her pink prosthesis, which looked both
primitive and futuristic, a long plastic tube
with five spindly mechanical fingers, novel in
its ability to help a child amputee regain hand
and arm function.
Sydney’s classmates called her famous.
Winter 2015–16
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Designed by three Washington University
seniors studying biomedical engineering and in
collaboration with Shriners Hospitals for Children
St. Louis and School of Medicine physicians such
as Goldfarb who provided medical expertise,
the pink prosthesis cost approximately $200 in
materials and took less than a week to print.
“My robotic arm was popular, and it made some
things easier,” Sydney said, “but, honestly, I had
grown used to doing things with my left hand
and sometimes it was easier not to wear it.”
Sydney also found the wire connecting the
shoulder sensor to the prosthesis cumbersome
and inconvenient.
Neither Sydney, her parents nor the three
undergraduate students who initially fabricated
the prosthesis expected perfection. Quite the
opposite. It was the students’ first attempt at a
pediatric robotic arm, and it wasn’t as if a successful prototype existed elsewhere. When the MIS
team got involved with the project, the prosthesis
impressed the scientists; however, they knew they
could make improvements. “We wanted to hear
what worked and what did not,” said Dominic
(Nick) Thompson Jr., a School of Medicine staff
scientist who is leading MIS efforts to create
pediatric prostheses. “Our goal is to do whatever
it takes, for however long, to help kids.”
Based on the family’s feedback, Thompson and
two Washington University biomedical engineering undergraduates working in the MIS lab —
Nabeel Chowdhury and Savannah Est — created
a second prosthetic arm for Sydney that offered a
wider range of wrist movement. Sydney controls
its functions through myoelectric technology that
uses electrodes to read the surface electrical current
generated when her arm muscles contract.
She received her new hand late last summer,
just in time for her first day of high school.
The prosthetic boasts fancy monogrammed
initials and a blue hue because, Sydney said,
“I got tired of everyone thinking pink was my
favorite color.” Perhaps an even bigger bonus for
the teenager: She can hold a cell phone with the
prosthetic hand and type with the other.
Not bad for the lab’s bulky 3-D printer that is
two years old and initially cost $2,500.
American engineer and physicist Charles Hull
developed 3-D printing — officially called stereolithography — during the 1980s for manufacturing purposes, according to the National Inventors
Hall of Fame. However, as technology advanced,
materials improved and the cost of both decreased
significantly during the past few years, 3-D

Fabricating custom prostheses has been a learning process for patients and researchers.
Charles Goldfarb, MD, evaluates Sydney Kendall, now using her second robotic hand.

printing has become the darling of the medical
and bioengineering industries.
A 3-D printer works similar to an inkjet
printer, Thompson said, but instead of ink printing letters and numbers, a 3-D printer uses spools
of plastic filament as “ink.” The plastic is heated
and extruded by the 3-D printer to form layers
to create 3-D models designed by researchers
using computer design software.
Although Sydney’s second prosthesis offered
significant improvement in aesthetics and weight,
it still had issues. The grip strength of the
prosthesis, for example, needed to be stronger
to allow Sydney to perform additional activities.
“Her feedback is invaluable,” Thompson said,
“because it brings us closer to creating a problemfree prosthesis.”
Chowdhury, the biomedical research engineering major, is devising plans for a third prosthesis
for Sydney. He plans to earn combined MD/PhD
degrees because he wants to specialize in 3-D
pediatric prostheses. “The need is great,” said
Chowdhury, who envisions the low-cost limbs
as options to help disabled children from lowincome areas both in the U.S. and abroad.
Outlook 13
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Evaluating her new
mechanical arm, Olivia
consults with her
research team:
(from left) Savannah Est,
Nabeel Chowdhury
and Nick Thompson.

L

iving without full use of her hands is
normal for Olivia. Although she was
born healthy, by four months of age
she mysteriously developed a rare
autoimmune disease — Infantile
Polyarteritis Nodosa/Atypical Kawasaki — that
inflamed her blood vessels and caused multiple
life-threatening aneurysms. To restore blood flow
and prevent infections, School of Medicine surgeons amputated Olivia’s right hand, the fingers
from her left hand and part of her right foot.
Almost 5 years old, Olivia walks normally and
her foot is unnoticeable with shoes. Her hands,
however, proved more challenging. Over the years,
she has perfected using her teeth (or her knees) to
steady objects, and uses her partial left hand and
her right wrist to grasp crayons or drinking cups.
“I do things different than my sisters,” said
Olivia, the second youngest of five sisters living in
Southern Illinois. “My mom says that’s OK.”
Despite her impressive ability to adapt without
hands, surgeons removed part of a bone in her left
hand to encourage a squeezing motion. For her

14 Washington University School of Medicine

right hand, the MIS lab’s Thompson, Chowdhury
and Est made Olivia a powdery-blue mechanical
prosthesis decorated with dinosaurs and her
name in cursive.
A mini-cable system in the mechanical hand
operates with the flex of Olivia’s wrist.
“Look at me, look at me,” Olivia shouted in
the lab last fall when she received her prosthesis.
The brown-haired precocious preschooler
practiced one-handed maneuvers such as
throwing a foam ball and holding a cup.
Her beaming brightness and obvious selfpride inspired a scientist’s eyes to mist.
But all wasn’t perfect. After a few minutes
wearing her prosthetic hand, Olivia dissolved in
frustration. Her arm muscles lacked the strength
to sustain movement in the mechanical hand.
The scientists noted possible modifications
for easier, prolonged movement and promised
Olivia another hand.
Est bent down toward Olivia’s level and
said, “One day, you’ll be able to print your
own hand yourself.”
Winter 2015–16

Charting the 3-D frontier
Surgical construction of an adult skull

Rendering of a pediatric patient’s skull

Model of an aorta

Model of a patient’s kidney with tumor

Learn more about the lab’s 3-D
design and printing services:

wuimis.wustl.edu

of the university’s innovations in 3-D
printing. As director of the Cleft Palate
and Craniofacial Institute at St. Louis
Children’s Hospital, Woo can correct
facial deformities using parts produced
on his department’s 3-D printer.
Another benefit is the potential for
reduced costs. Traditional robotic limbs
can cost between $50,000 to $70,000.
Materials for a 3-D prosthesis hover
closer to $200. But price comparisons
can be misleading: Pediatric limbs cost
a few hundred dollars in materials but
that doesn’t include scientists’ labor
or capital investments, with some 3-D
printers running as high as $350,000.
The medical school has only a few
3-D printers; both Brunt and Woo
emphasized the need for more to stay
at the forefront. “Three-dimensional
printing in the medical field is in its
infancy,” Woo said. “It’s exploding
with opportunities and transforming
health care.”

“Hardly a day goes
by that I don’t hear
of something new.”

ERIC YOUNG

T

he Minimally Invasive Surgery
Biomaterials Lab and the Division
of Plastic and Reconstructive
Surgery are collaborating on a growing
list of 3-D printing innovations.
“There is tremendous excitement at
Washington University and other universities about devising medical applications for 3-D printing,” said L. Michael
Brunt, MD, chair of the MIS lab and a
professor of surgery. “Hardly a day goes
by that I don’t hear of something new.”
Two years ago, the lab became
involved in 3-D printing to design and
fabricate hernia surgical mesh. As interest grew, so did the opportunities.
MIS scientists have ventured into
creating plastic organs such as kidneys
and uteruses for surgical training tools
as well as developing techniques for
bio-printing, in which living cells are
used to form structures.
Anatomical models printed directly
from CT scans allow physicians to
evaluate patients with extraordinary
precision, said Albert S. Woo, MD, associate professor in plastic and reconstructive surgery, who is leading many

L. Michael Brunt, MD

Uterus and cervix disassembled for study

Experimental modeling of aortic valve
outlook.wustl.edu

The aortic valve, created using hydrogel, is a first step toward printing with living cells.
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Building
better

S

U C K I T U P. When it comes
to chronic injuries, that’s been
the mantra in the macho, maledominated, highly competitive culture
of commercial construction. However,
industry experts and younger generations
of construction workers are realizing that
attitudes and behaviors must change for
safety to improve.
The sector has made major
strides in reducing acute injuries
from construction-site accidents.
Less attention has been placed
on preventing musculoskeletal
injuries caused by force, repetition, awkward
posture and overexertion. The costs are great,
both to the company and the individual.
Such injuries make workers less effective,
potentially more dangerous, and often result
in prolonged absences and early retirement.
Is it possible to modify these physically
demanding jobs? And, if so, what’s the
most effective way to reach millions of
front-line workers?

HEALTH
Keeping the toughest jobs safe
requires boots-on-the-ground
research and a can-do company
attitude. A campus building project
is putting these ideas in motion.
B Y D E B PA R K E R
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As it turns out, St. Louis is the perfect backdrop to
find the answers; it is home not only to offices of the
safety-conscious Clayco, a national innovator in the
design-build industry, but also to School of Medicine
occupational health experts who are among a handful
of researchers worldwide dedicated to measuring and
improving the safety climate in construction.
Together, the medical school team and Clayco won a
$1 million, five-year grant from the National Institute of
Occupational Safety and Health and the CPWR Center
for Construction Research and Training. Through this,
an on-campus building project is serving as a research
lab of a different sort.
Now, as tradespeople labor on Mid-Campus Center,
an administrative building for the medical school and
Barnes-Jewish and St. Louis Children’s hospitals, the
researchers methodically observe. The hope is that the
resulting recommendations will be adopted into construction safety management systems around the country.
Headed by Bradley A. Evanoff, MD, the Richard A.
and Elizabeth Henby Sutter Professor of Occupational,
Industrial and Environmental Medicine and director
of the Division of General Medical Sciences, the team
conducts research on improving health and decreasing
disability among working populations.
Over the past 20 years, the researchers have embarked
on a wide range of studies: smoking cessation among
blue-collar workers; carpal tunnel syndrome; welding
exposures; back injuries in health-care professionals;
outlook.wustl.edu

THE GOA L
National impact in
construction safety
and obesity intervention programs in the workplace.
These community-based studies often have involved
recruiting large numbers of employees and cooperating
closely with employers and labor unions.
One such study focused on fall prevention in
residential construction. The team’s Vicki Kaskutas,
OTR/L, OTD, helped the St. Louis Carpenters Joint
Apprenticeship Program improve training, adding a
mock house showcasing safety equipment and a dummy
to demonstrate fall arrest gear. (Later, the Occupational
Health and Safety Administration hailed Kaskutas’ website cataloguing 150 fall prevention devices as the most
comprehensive resource of its type.) John Gaal, EdD, of
the Carpenters’ District Council of Greater St. Louis &
Vicinity, said that the house mock-up and its fall demonstrations became “the world model to teach fall protection.” He added: “Until you have a tier-one institution
like Washington University doing this research, industry
won’t listen. There is no doubt that we are safer now.”
Eventually, researchers turned their attention to
commercial construction workers, who face myriad
risks in ever-changing, complex environments.
Outlook 17

A DEADLY FOUR, PLUS ONE
Years ago, OSHA identified the four leading causes of
fatalities in construction. These are known as the Focus
Four: electrical, struck-by, caught-in-between and falls.
An OSHA training course educates workers on how
to avoid such dangers, and these four categories are the
primary focus during federal inspections of construction
sites. Because of sustained attention at multiple organizational levels, these hazards have been significantly reduced.
However, musculoskeletal injuries — low back pain,
knee injuries, tendonitis, torn rotator cuffs and carpal
tunnel syndrome — remain commonplace. Many
construction-related tasks push the human body beyond
its natural limits as workers lift heavy materials, hold
vibrating equipment, apply force, bend, kneel, twist, grip
and reach overhead.
School of Medicine researchers suggest adding one more
important area of emphasis: ergonomics.
The science of ergonomics examines the relation
between workers and their environments. This approach
identifies uncomfortable or difficult tasks and seeks practical, adaptive solutions for improvement. The goal is to
make sure workers stay safe, comfortable and productive.
Traditionally, ergonomics programs have been viewed
as an add-on to safety programs, lacking the management support and commitment necessary to bring about
changes in behavior and work design.
“Reducing chronic injuries has taken a backseat to acute
injuries,” Evanoff said. “For good reason. Acute injuries
cause many fatalities. Chronic injuries are just accepted
as part of the job. We want to know — are there ways to
keep productivity up, without beating the body up in the
process? Can we do a better job of affecting chronic disease?”

Construction work
pushes the human body
to its limits, and beyond
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THE CHALLENGE
At the Mid-Campus Center
construction site, Hector Lozoya,
senior safety engineer for Clayco,
discusses progress with occupational
health researcher Brad Evanoff, MD.
Winter 2015–16
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THE INDIVIDUAL WORKER
In earlier studies, principal investigator Ann Marie Dale,
PhD, research assistant professor of medicine and occupational therapy, learned that individual construction workers,
while willing to adapt, lacked the power to change the culture.
Over a five-year period, the team worked with seven
different subcontractors on job sites. There, they observed
sheet metal workers, floor layers, carpenters and other
tradespeople in action, photographed their activities and
engaged in dialogue. Each week, Dale participated in “toolbox talks” to discuss improving ergonomics. The team also
created sets of laminated safety cards. Bound to carabineers
for quick, easy access, these card sets gave tips on how to lift
properly, minimize vibration and choose hand tools.
As Dale built trust within St. Louis construction trades,
she began evaluating the effectiveness of participatory ergonomics — leveraging worker experience to identify and
correct factors that negatively affect health. After training,
workers improved the safety and healthfulness of their work
by trying new tools and changing the way they performed
tasks. For example, floor layers proposed using an extended
handle on spray cans to reduce the time spent kneeling. Dale
also realized that a construction worker is more likely to
invest in a safer hand tool than a subcontractor is to purchase
a safety device or service a lift to keep it operating safely.
In a remodeling project, workers were removing old
carpet from classrooms. Sometimes workers pulled carpet
by hand; other times they used an automatic puller. The
device required significantly less hand force, but, as several
workers were performing this task at different sites, its
availability depended upon coordination with management.
“What we found is that construction workers don’t
have enough control over their environment,” said Dale,
who is triple-certified in ergonomics, occupational therapy
and hand therapy. She realized she needed to go higher
in the organization.
“Workers made changes, but not enough to reduce
symptoms. Giving knowledge is not enough. Construction
managers such as Clayco define the safety of the workplace.
They can require safe practices from their subcontractors,
so they can have the greatest influence on worker safety.”

20 Washington University School of Medicine

Onsite dialogue and observation have proven critical for understanding
the constantly changing construction environment. Ann Marie Dale, PhD,
queries Bob Hohman and Scott Sams.

THE SYSTEM LEVEL
About the same time Dale was working to secure grant
funding for a project involving a construction manager,
Clayco was looking for ways to better integrate ergonomics
into its safety program. “Clayco recently added overexertion
as it fifth focus area, but, as a company, we hadn’t yet put
structure around it,” said Todd Friis, vice president of risk
management at Clayco, who regularly conducts safety
audits at about 30 job sites across the country.
The team now is studying how the safety climate set by
a construction manager affects the behavior and attitudes of
subcontractors and their employees. “We know that some
subcontractors improve their safety procedures to qualify
for work with safety-conscious construction managers,”
Dale said. “We’re trying to see if such changes persist and
how they happen, and whether the safety requirements of
the larger construction managers help shape the regional
safety culture among smaller contractors.”
Team members regularly visit the Mid-Campus Center
site, recording current practices and assessing safety
knowledge among workers.
Walking about the site, Dale makes comments: “That
piece of equipment is too heavy for that worker. If that
task was being performed at waist-level instead of on the
ground, he wouldn’t have to strain so much.”
“We are giving them our eyes … what’s good and bad
related to ergonomics,” Dale added. “Our role is to build into
their safety program so they can use that knowledge every day.”
Winter 2015–16

Researchers attend the morning huddles, which include
a mix of safety information and warm-up exercises. “The
huddles set the tone,” Friis explained. “Every day we ask,
‘What are the risks today based on my scope of work?
What do I need to mitigate?’”
Remaining cognizant of tight production schedules,
the research team is gaining information from the workers,
both through on-site interaction and surveys.
“The survey questions are clever,” Friis said. “One
question asks whether the worker has ever been hurt by
overexertion. And, of course, most answer no. Another
question asks whether a partner or buddy has ever been
injured. And, of course, they all answer yes. They may not
say it about themselves, but they’ll say it about a buddy …
injuries that, up until now, haven’t come to the surface.”
Direct feedback from workers is crucial, Evanoff said.
“It’s truly been a participatory model. We can come in and
see hazards, but to make changes, we need the day-to-day
collaboration. They’re the ones with the deep knowledge.
Describing the risk factors, in retrospect, is the easy part.
How to reduce risk factors in a complicated, dangerous,
dynamic environment — that’s the tough part. It takes a
deep understanding of what the work is like.”
Researchers also participate in Clayco’s weekly planning meeting, talking through the next phases of construction. Their questions are specific: How are you going to
transport that rebar? How are workers lifting those panels?
Ergonomics is about anticipating all the steps and putting
the best tools and equipment in place beforehand.
In addition, the researchers are reviewing Clayco’s
monthly safety dashboards, which list total reported
injuries and their causes. “It’s full disclosure,” Friis said.
“It’s like looking in our sock drawer.”

THE CHANGE
Reducing risk requires a
deep understanding of
the work that can only
come from the workers

outlook.wustl.edu

A MODEL TO EMULATE
In the end, the researchers will propose ideas to benefit
workers and help eliminate soft-tissue injuries. Clayco
will decide which changes to adopt as part of an enhanced
safety and ergonomics program.
“In the next months, this will move from observation to
tactical implementation,” Friis said. “That’s been the real differentiator here. This isn’t someone sitting at a computer running reports, but researchers who are interacting in the field.”
Friis credits Dale as someone with “the right skill level
and temperament to work with our guys. She has spent a
lot of time in the field and it comes across.”
Dale, co-chair of the building and construction committee for the International Ergonomics Association, travels
globally to network and share knowledge with a small
niche of likeminded researchers.
“For Clayco, it’s been great to partner with such passionate people as we consider how to enhance our program,”
Friis said. “The enthusiasm rubs off on our guys. And it
keeps them on their toes. Here are people with PhDs
evaluating and assessing our programs.”
“All the guys are talking about it,” said Hector Lozoya,
Clayco senior safety engineer. “It will be very interesting
to see what they find, what their recommendations are and
how it will affect productivity. Are big companies willing
to make the changes?”
Recently, Clayco CEO Bob Clark temporarily halted
operations at the site when he spotted something he
thought was unsafe.
Lozoya recalled: “Some of the guys were worried about
deadlines and kind of grumbling. I said, ‘Let’s not look at
it that way. You are working for an owner that’s concerned
about your safety. Everyone’s going to go home at the end
of the day.’”
Ultimately, new protocols could be developed in many
key areas, such as orientation and training, written policies,
signage, bidding procedures and inspection forms. A year
after the changes, the researchers plan to come back, survey
workers and make comparisons.
The goal is to create a program that exerts influence
regionally and nationally. “Obviously, we have to get buyin from all levels — owner to worker — so safety and ergonomics are incorporated into every aspect of the process
and simply become the way we do business,” Friis said.
“Really, our interest is the whole industry,” he added.
“We want to go big with this. This is a significant opportunity
to transform the industry.”
Outlook 21
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One new test
detects all
likely suspects

e

plague the human body, spawning
everything from the mildly annoying

common cold to deadly illness, and new
threats continue to appear. When serious
disease strikes, the question immediately
becomes: “Which virus is it?”
Doctors must act on well-informed
suspicions to order the necessary tests.
And low levels of bad bugs can evade
detection. Even after an exhaustive
workup, the cause may remain a mystery.
A new test developed at Washington
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University School of Medicine is capable
of detecting virtually any virus that infects
people and animals and could make such

The wheel represents
the various viruses,
classified into families
and by genetic
makeup, found in
the new ViroCap test.
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HOUSANDS OF VIRUSES

uncertainty a thing of the past.
BY CAROLINE ARBANAS
AND GAIA REMEROWSKI
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“With this test, you don’t have to know what you’re looking for,”
said Gregory A. Storch, MD, the study’s senior author
and the Ruth L. Siteman Professor of Pediatrics. “It casts a
broad net and can efficiently detect viruses that are present
at very low levels. We think the test will be especially
useful in situations where a diagnosis remains elusive
after standard testing or in situations in which the cause
of a disease outbreak is unknown.”
The test could be used to detect outbreaks of deadly
viruses such as Ebola, Marburg and severe acute respiratory
syndrome (SARS), as well as more routine viruses, including
rotavirus and norovirus, both of which cause severe gastrointestinal infections. Storch’s team already used an earlier
version of the test to determine which particular strain
of the respiratory virus, enterovirus D-68, was causing an
outbreak of unusually severe illness in children last year.
The Washington University team is making
the technology publicly available for the benefit
of patients and research.
Developed in collaboration with the
university’s Elizabeth H. and James S.
McDonnell III Genome Institute,
the new test sequences and detects
viruses in patient samples and is

ROBERT BOSTON

Kristine Wylie, PhD, and Todd Wylie — lab and life
partners — genetically identify viruses using fast,
efficient high-throughput sequencers.
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Because the test includes detailed genetic information
about various strains of particular viruses, subtypes can be
identified easily. An example of this is the influenza virus,
which may change yearly and has a variety of subtypes that
could be responsible for a given outbreak. In the study, standard testing identified influenza A. The new test also could
detect changes in the genome and indicated a particularly
harsh subtype of the virus called H3N2.
Last flu season, H3N2 contributed to some 36,000 deaths
in the U.S. For some patients, particularly young children,
older adults and people with weakened immune systems,
knowing that the H3N2 strain is present may alter treatment.
To develop the test, the researchers targeted unique
stretches of DNA or RNA from every known group of
viruses that infects humans and animals. In all, the research
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including blood, stool and nasal secretions — from patients
at St. Louis Children’s Hospital. The MSS test detected
Iridoviridae
viruses in 10 of 14 patients. But the new ViroCap test
found viruses in the four children that earlier testing
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everyday viruses, including influenza B, a cause of seasonal
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herpes virus 1, responsible for cold sores in the mouth; and
varicella-zoster virus, which causes chickenpox.
In a second group of children with unexplained fevers,
MSS testing had detected 11 viruses in the eight children
evaluated. But the new ViroCap test found another seven,
including a respiratory virus called human adenovirus B
type 3A, which usually is harmless but can cause severe
infections in some patients.
In all, the number of viruses detected in the two patient
groups jumped to 32 from 21, a 52 percent increase.
“The test is so sensitive that it also detects variant strains
of viruses that are closely related genetically,” said corresponding author Todd Wylie, an instructor of pediatrics.
“Slight genetic variations among viruses often can’t be
distinguished by currently available tests and complicate
physicians’ ability to detect all variants with one test.”
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just as sensitive as the gold-standard polymerase chain reaction (PCR) assays, which are used widely in clinical laboratories. However, even the most expansive PCR assays can only
screen for up to about 20 similar viruses at the same time.
Results published in the journal Genome Research
demonstrate that the new test, called ViroCap, can detect
viruses not found by standard testing of patient samples.

More research is needed to validate the test’s accuracy, so
it could be several years before becoming clinically available.
Already, the test is being used on patients enrolled in a
clinical trial led by Storch.
“I think that in the future this test will provide information that will become very useful in clinical medicine far
beyond what we get from an ordinary PCR test,” Storch said.
For now, scientists can use the technology to study
viruses. Co-author Kristine Wylie, PhD, investigates the
viruses that set up residence in and on the human body,
collectively known as the virome. The test will provide a
way to capture the full breadth and depth of such viruses
and deepen understanding of how they play a role in
keeping the body healthy.
“It also may be possible to modify the test so that it
could be used to detect pathogens other than viruses,
including bacteria, fungi and other microbes, as well as
genes that would indicate the pathogen is resistant to
treatment with antibiotics or other drugs,” said Kristine
Wylie, PhD, an assistant professor of pediatrics.
“I think we’re going to see an explosion of research that
grows out of this and it will have tremendous applications,”
added Storch. “It will go far beyond what we’ve done.”
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legacy

Victoria Fraser, MD, with donors John C. Shapleigh
and Camilla “Kimmy” Shapleigh, whose late
husband John B. Shapleigh II, MD, foresaw the
need for improved hospice care. A new educational
fund will further that mission.

Palliative care

PROGRESS
Shapleigh family legacy
ensures dignity, care
and compassion for those
living with chronic disease
and at the end of life
BY HILARY DAVIDSON
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A

lthough Americans are living longer due to
advances in U.S. health care, many suffer
from chronic health problems that may
cause years of pain and distress. Palliative care
focuses on managing symptoms and improving the
quality of life for patients with serious acute and
chronic illnesses. Nationally, there is a shortage of
fellowship-trained, board-certified palliative care
and hospice physicians, putting these experts in
high demand. The School of Medicine is expanding
efforts to train a new generation of such specialists,
aided by a generous donation from a local family.
The terms “hospice” and “palliative” care
sometimes are used interchangeably. But hospice
care provides comfort to those with a life expectancy
of six months or less. Palliative care specialists
manage patients’ ongoing physical and psychological
symptoms, requiring multidisciplinary approaches
and effective communication between the patient,
the patient’s family and the medical staff.
Winter 2015–16
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“Many chronic diseases have multiple
symptoms that are difficult to manage.
Although not life-threatening, these
symptoms can be quite disabling and
disheartening for patients and their
families,” said Victoria Fraser, MD, chair
of the Department of Medicine and the
Adolphus Busch Professor of Medicine.
“Reducing these symptoms and helping
people be as active as they can be and as comfortable as
they can be, is really the goal of palliative care.”
In memory of a man who dedicated his life to compassionate care, family members recently endowed the
Dr. John B. Shapleigh II Hospice and Palliative Care
Education Fund. This fund is helping the School of
Medicine grow its hospice and palliative care education
program to meet increasing demand.

Shapleigh’s caring mission
In the 1970s, Shapleigh, MD ’46, pioneered hospice care in
St. Louis. In the 1990s, he worked to create and manage the
region’s first stand-alone hospice house, de Greeff Hospice
House, which has helped thousands of patients and families,
and is still in operation today.
Later, he turned toward advocacy, forming the Hospice
Foundation of Greater St. Louis with his son, John C.
Shapleigh, LW ’76. The nonprofit served as an educational
resource for health-care providers, patients and their
families from the late 1990s to the mid-2000s.
Shapleigh II died in 2011. However, his wife, Camilla
“Kimmy” Shapleigh, along with John C. Shapleigh and his

+
100
years of
dedication
The Shapleighs and
Washington University
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John B.
Shapleigh II,
MD, pioneered
hospice care in
St. Louis.

wife, Anne, also LW ’76, are
committed to furthering this
work. “We thought this would be
consistent with the original purpose
of the Hospice Foundation of
Greater St. Louis, and continue
to carry out my father’s mission,”
said John C. Shapleigh.

A broad initiative
The fund is the first step in an initiative that will include
a new outpatient clinic, a fellowship program, a research
program and more extensive general educational programs.
The medical school is recruiting physician faculty who
are board-certified in hospice and palliative care to treat
patients, establish best practices and train future providers.
“We want to raise the level of general knowledge among
providers and create more palliative care and hospice specialists,” said Maria Dans, MD, assistant professor of internal
medicine and clinical director of palliative care services.
Educating more doctors will improve patients’ access to
better palliative and end-of-life care, Fraser said. “One of the
challenges is that many patients are not referred to palliative
care or hospice care until just a few days before they die,” she
said. “If we can do a better job of educating everyone and get
more patients into care, we can reduce pain and suffering
and prevent unnecessary hospitalizations, readmissions and
trips to the emergency room for pain or symptom control.”
“This wonderful gift provides a tremendous jumpstart
for us at an opportune time,” Fraser added. “Palliative and
hospice care are important, not only here but nationally.”

T

hrough this latest donation, the Shapleighs
build on an impressive legacy of service to
the university. Anne and John C. Shapleigh have
generously supported School of Law scholarships, and many family members have attended
the university. The Shapleighs’ connection to
Washington University began over a century
ago when John Blasdell Shapleigh I, John C.’s
great grandfather, rose to prominence in the
newly formed Washington University School of
Medicine. From 1896 –1923, he was professor
and chair of the Department of Otology (now
Otolaryngology), and served as dean of the
faculty in 1901– 02. Committed to education, he
endowed a scholarship for two medical students
that continues to shape the future of medicine.

John Blasdell Shapleigh I, MD
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Journey
through
Parkinson’s
Dedicated family
forges partnership,
brightens hope
for alleviating
the disease
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J

oel S. Perlmutter, MD, the Elliot Stein
Family Professor of Neurology and director
of the Movement Disorders Section at the

School of Medicine, still carries the small pocket

knife that patient Frederick G. Oertli gave him
some 15 years ago. “I’ve always treasured it,”
Perlmutter said. The tool is a reminder of a
patient and his family who became friends,
then partners in research.
Oertli, AB ’55, formerly a principal at
Guarantee Electrical Co., was diagnosed with
Parkinson’s disease in 1993. In 1999, he became
Perlmutter’s patient, and remained under his
care until his death in 2014.

Winter 2015–16

At first, Oertli went to medical appointments alone. As
his condition worsened, his wife, Jo, accompanied him, and
she became increasingly interested in Perlmutter’s research.
Perlmutter encouraged the Oertlis to learn as much as
they could about Parkinson’s disease, a degenerative condition characterized by the death of dopamine-producing neurons in the brain. Lack of dopamine, a neurotransmitter that
helps nerve cells “talk” to each other, results in motor symptoms such as shaking, slowness and difficulty of movement,
and, as the disease progresses, dementia. Deep brain stimulation and the medication levodopa alleviate symptoms,
but there is no known cure.

Joining the effort
The Oertlis became active in the St. Louis chapter of the
American Parkinson’s Disease Association. After meeting
others who were also touched by the disease, the Oertlis
decided to invest in research, and made a gift to Washington
University for Perlmutter’s work. Jo Oertli continues her
support, and finds comfort in being part of the effort to
better understand and treat the illness.
The Oertlis’ contribution has expanded research possibilities by supporting aspiring physician-scientists at the School
of Medicine early in their careers. “For the last three years,
the Oertlis have funded our fellows,” Perlmutter said. Two
former “Oertli fellows” now work alongside Perlmutter as faculty members, and several new fellows are training with him.
Perlmutter studies the disease on many fronts: researching new drugs, developing ways to image the brain and
examining the link between Parkinson’s disease and dementia, to name a few. However, Perlmutter emphasized, the
most important way to move the field forward is by training
young scientists who will continue the work.

Fine-tuning treatment options

ROBERT BOSTON

The Oertlis’ support was a game-changer for Mwiza Ushe,
MD/MA ’07, HS ’11, assistant professor of neurology
and director of the Deep Brain Stimulation Program for
Parkinson’s Disease and Tremor. “Without the Oertlis’
support that first year as a fellow, there’s no way I would
have had time to collect enough data to write a grant and
get funding to begin my career,” Ushe said.
In the critical juncture between residency and fellowship,
many would-be researchers are not able to support themselves while they conduct enough research to successfully
compete for grants. Federal funding for training dollars is

Joel S. Perlmutter, MD, with Jo Oertli and David M. Holtzman, MD,
head of the Department of Neurology.
outlook.wustl.edu
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Imaging studies reveal
the impact of Parkinson’s
disease deep within
the brain.

scarce, and competition is fierce. “This is where a lot of very
smart residents and fellows give up on research,” Ushe said.
Ushe is focused on better understanding how deep brain
stimulation (DBS) works to optimize its use.
DBS is a non-drug treatment for motor symptoms of
Parkinson’s disease. In DBS, a small electrode is surgically
placed in a tiny area deep in the brain called the subthalamic
nucleus (STN). The electrode sends electrical pulses through
the brain, helping the patient to complete movements
disrupted by Parkinson’s disease. Although DBS is effective,
scientists aren’t sure how it works, and the surgery for electrode placement is invasive.
Initially, it was believed that patients would benefit
only from stimulation of the upper STN. However, with
Perlmutter’s guidance, Ushe and his colleagues found that
stimulation of other locations of the STN also helped.
Positron emission tomography (PET) images of the brains
of test subjects showed that stimulation of various parts of
the STN triggered different neuronal pathways.
“What we’re starting to show is that you can stimulate
in different parts of the STN and see the same output and
improvement in function, but the brain actually is using different pathways to get that same improvement,” Ushe said.
Led by Perlmutter, the team is contributing to scientific
understanding of the causes and mechanisms of Parkinson’s
disease, moving the field toward a time when Jo Oertli’s
dream of a cure will be fulfilled.
“It’s a horrible disease,” said Jo Oertli. “That’s why I am
committed to finding a cure. I am confident that someday
it will happen, thanks to the dedicated work of doctors
like Joel Perlmutter and his colleagues.”
Outlook 29
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Going places
Cynthia A. Wichelman, MD
(foreground), associate
professor of emergency
medicine, leads second-year
students on a spring break
trip to Guatemala, where they
helped care for patients.

Alumni philanthropy
supports student
activities, spreads
School of Medicine
mission worldwide

S

chool of Medicine students are benefiting today
from scholarships and opportunities to do community
service or study abroad, thanks to the generosity of

those who went before them.
“Alumni annual support helps our students become better
physicians by providing opportunities to practice clinical

skills, take on leadership roles and build relationships,” said
Greg Galakatos, MD ’91, HS ’96, president of the Washington
University Medical Center Alumni Association (WUMCAA).
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2%
6%
WUMCAA recently allocated more than
$235,000 from the medical school’s Annual Fund,
an account that is supported by unrestricted gifts
up to $999 from alumni and former house staff.
More than 1,300 donors contributed an
average of $159 each; together, these contributions
are making a major difference in the education
and training of School of Medicine students.
Scholarships are chief among WUMCAA priorities. This year, the association’s Executive Council
allocated $160,000 toward the Distinguished
Alumni Scholarship Program (DASP).
Since 1989, four students annually have been
granted four-year, full-tuition DASP scholarships,
funded in part by Annual Fund gifts. In addition,
WUMCAA’s Executive Council selects four outstanding alumni faculty members — one per
scholarship — to honor as namesakes, helping to
spark mentoring relationships with the recipients.

24%

Scholarships: 68%

WUMCAA
funding
allocation

Student groups,
educational initiatives and
community outreach: 24%

68%

Other student activities: 6%
Academic and honor
societies: 2%

The Geriatrics Outreach
Group organizes an annual
“Senior Prom” and other
intergenerational events.

T

he second largest funding allocation went
to student groups. As part of the funding
process, student leaders are asked to
prepare proposals on behalf of their
organizations, and the Executive Council selects
projects to support.
Many of these endeavors enable students to
expand their knowledge base while serving the
community. These experiences help students
prepare to meet the challenges of providing
21st-century health care.
For example, more than 90 percent of medical
students participate in the Saturday Neighborhood
Health Clinic, which provides health care to
uninsured patients in St. Louis City.
Student volunteers with the Young Scientist
Program teach hands-on scientific investigation to
disadvantaged youth in hopes of fostering interest
in STEM (Science, Technology, Engineering and
Mathematics) careers. Along the way, medical
students develop communication and leadership
skills as well as new perspectives on issues facing
urban youth.
Those who participate in the Geriatrics
Outreach Group organize a yearly “Senior Prom,”
a free event featuring live music, dancing,
dinner and intergenerational fun for students
and St. Louis elders. Through social interactions
such as this, students gain an understanding of
the medical and social challenges experienced
by older adults.
outlook.wustl.edu

Medical students involved with
the Young Scientist Program
teach hands-on science
investigation to area youth.

More than 90 percent of
medical students participate
in the Saturday Neighborhood
Health Clinic, which provides
health care to uninsured
patients in St. Louis County.
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WUMCAA leadership
Sylvia Awadalla, HS 89

Charles Harris, MD/
PhD 02

Fred Balis, MD 89, HS 92

James Keeney, MD 93

Marc Bernstein, MD 92

Judy Lieu, MD 92, HS 98

Thomas Blanke, MD 71

Robert McMahon,
MD 89, HS 92

Jim Avery, HS 93

Andy Blatt, MD 92
Archna Calfee, MD 01

Andy Mohapatra, MD 16

Gregory Cizek, MD 90

Lisa Moscoso, MD/PhD
98

Jeff Crespin, MD 93,
HS 96

Linda R. Peterson,
MD 90, HS 93

Tom De Fer, HS 92

Paul Robiolio, MD 89

James W. Forsen Jr.,
MD 88, HS 94

Joel Schilling,
MD/PhD 03, HS 09

Gregory Galakatos,
MD 91, HS 96

Mary Beth Scholand,
MD 90

Harvey Glazer, MD 76

Alistair Scriven, MD 90

R. Mark Grady, MD 89

Emily L. Smith, MD 68

Ian Hagemann, MD/PhD
08, HS 12

ROBERT BOSTON

Connections
promotes inclusion
and cultural awareness
among students.

UMCAA also is supporting the new
student-led initiative Connections,
which aims to improve the student
experience by promoting inclusion
and cultural awareness. In the stressful environment of graduate school, students tend to cluster with
people like themselves, said co-founder Jessica Miller,
an MD/PhD student in biomedical engineering.
Connections works to help students transcend
this behavior by offering seminars on diversityrelated topics and facilitated discussions. Such
events help dissolve barriers by giving people the
chance to honestly ask questions and learn
from each other, Miller said.
Miller believes students need communication
skills, not just for patients, but also to have meaningful interaction with their peers.
WUMCAA also funds study abroad. Each year,
the Forum for International Health and Tropical
Medicine (FIHTM), the medical school’s global
health interest group, sends students to locations
such as Guatemala, Thailand and Malawi where
they interact closely with faculty participating in
research or health care. Upon returning, students
share their findings at an annual university-wide
global health symposium. Opportunities are expansive as FIHTM seeks to prepare students for a global
understanding of the intricacies of health care.
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classnotes
1930 S
Yvonne Bost Pickett, NU 38, published a
memoir of her years as a nurse at Queen’s
Hospital in Honolulu during World War
II, titled “Our War: My Life as a Nurse in
Hawaii, 1941-1945.”

1950 S
Lynn Frerking, NU 54, retired in 1997
after working as both a medical and surgical nurse but stays involved in the medical
field as a hospice volunteer. She and her
husband, Ken, have enjoyed watching
their grandchildren grow and spend their
free time keeping active. They will celebrate their 60th anniversary next year.

1960 S
Earl Hearst, MD 69, LA 66, and his playing partner won a bronze medal for men’s
doubles in pickleball at the Maryland
Senior Olympics.

1970 S
Jerry Schriver, HA 71, is pleased to
announce that his daughter, Elizabeth, is
attending Washington University School of
Law, and he recently enjoyed visiting her
on campus.
Mark Braunstein, HS 75, teaches at the
Georgia Tech College of Computing in
Atlanta, is associate director for health
systems at the Institute for People and
Technology and associate editor of the
IEEE (Institute of Electrical and Electronics
Engineers) Journal of Biomedical and
Health Informatics. He is also an invited
contributor to the InformationWeek
health-care blog and founded several
successful health IT companies. His book,
“Practitioner’s Guide to Health Informatics,”
was published in spring 2015.

outlook.wustl.edu

Promising students matched with faculty mentors
Recipients of the Distinguished Alumni
Scholars Program (DASP) scholarships are
matched with an outstanding alumni faculty member, opening the door for mentoring. This year’s DASP honorees and
scholarship recipients are: (from left) C.
Robert Cloninger, MD ’70, HS’ 73, the
Wallace Renard Professor of Psychiatry,
and Kevin Garza; Thomas J. Baranski, MD/

1980 S
David J. Baltzer, HA 81, is president-elect
of the Missouri Health Executives Group,
the Missouri chapter of the American
College of Healthcare Executives.
Vicki Smith, OT 86, received a Roster
of Fellows award from the American
Occupational Therapy Association and is
associate vice president for program development at Keuka College in New York.

1990 S
Howard Epstein, MD 91, LA 86, recently
joined the executive leadership team at
PreferredOne health plan in Minnesota as
executive vice president and chief medical
officer. He is a volunteer for Washington
University, serving on the Alumni Board of
Governors, and is active with the Greater
Twin Cities United Way.
Charles W.M. Roberts, MD 95, GM 95,
has been named to head the cancer center
at St. Jude Children’s Research Hospital in
Memphis, Tenn. He will serve as executive
vice president and director of the St. Jude
Comprehensive Cancer Center and as the
Lillian R. Cannon Comprehensive Cancer
Center Director Endowed Chair in the
Department of Oncology.

PhD ’92, associate professor of medicine
and of developmental biology, and
Stephen Hawn; Thomas C. Bailey, MD ’84,
HS ’87, professor of medicine, and Weston
McCarron; and David A. Hunstad, MD ’95,
HS ’98, chief, Division of Pediatric Infectious
Diseases, associate professor of pediatrics
and of molecular microbiology, and
Daniel Friedman.

Mario Harding, HA 96, was named associate chief operating officer of ancillary
services at Denver Health. He has been
with Denver Health for nine years, most
recently as the Department of Medicine’s
administrative director. Harding joined
Denver Health in 2006 as the administrative director of Behavioral Health Services
and received the CEO Commendation
Award in the Department of Behavioral
Health in 2010. He will support the current
leadership in the areas of lab, radiology,
pharmacy and perioperative services with
administrative and managerial oversight
of patient care, staff development and
education. Harding is a fellow with the
American College of Healthcare Executives.

2000 S
Christina Ahn Hickey, MD 09, GM 09,
is on the faculty of the Division of Pediatric
Gastroenterology, Hepatology and
Nutrition at Washington University School
of Medicine. She enjoys spending time
with her daughter, Olivia Marie, and is a
freelance editor for an indie publishing
company.
William McCoy IV, MD 13, was awarded a
clinical research grant from the American
Acne and Rosacea Society.

Outlook 33

classnotes
In Memory
A LU M N I

Career in motion

PT alumna tests split-belt treadmill on stroke patients

W

alking on a split-belt treadmill —
with one leg stepping forward,
the other backward and both moving
at different speeds — sounds tricky, but
people adapt quickly, said alumna Amy J.
Bastian, PhD, PT ’95, recently named the
first chief science officer at the Kennedy
Krieger Institute in Baltimore.
“It isn’t hard at all!” Bastian said.
“People do this readily.”
Bastian is using the device to probe
how the nervous system controls movement and to help neurologically impaired
patients regain motor skills. Early studies
suggest that the treatment rewires the
brain, temporarily improving asymmetric
walking patterns in stroke survivors.
When healthy people walk on a splitbelt treadmill, with one belt moving
three times faster than the other, they
immediately take a larger step on one
leg. In other words, they limp. But within
minutes, they self-correct and resume
an even stride. Once both belts return
to normal speed, most people find they
cannot walk normally. The newly learned
pattern must actively be unlearned.
With stroke patients, researchers use
the treadmill to make limps worse, driving the nervous system to adapt. “Just
like we trained a limp into a healthy person (albeit temporarily) we train a limp
out of a stroke survivor,” she said.
The research demonstrates how
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new motor patterns are stored and how
people with brain damage respond
differently.
“We already appreciate that the brain
is very plastic and responds rapidly to
reflect even simple patterns of movement
training,” Bastian said. “I imagine that we
will become much more sophisticated
in the future by using combinations of
motor pattern training, non-invasive brain
stimulation, pharmaceutical interventions
and general exercise to improve movement and change brain function.”
Bastian, who has coauthored more
than 100 scientific papers and many
book chapters, received a prestigious
Javits award from the National Institutes
of Neurological Disorders and Stroke.
She recalls Washington University as
a scientifically exciting, nurturing place
to work and credits two special mentors:
the late Tom Thach Jr., MD, a pioneering
brain researcher and professor of neurology and physical therapy, and Shirley A.
Sahrmann, PT, PhD, professor emeritus
of physical therapy, of neurology and of
cell biology and physiology.
“Tom taught me how to think about
difficult problems and devise simple
solutions. I miss him very much,” Bastian
said. “Shirley is one of the rare individuals who makes you want to be better at
everything you do.”

John A. Headrick, MD 58
Headrick died Monday, July 20, 2015. He
was 83. Headrick worked for many years
in internal medicine at Christian Northeast
Hospital. He was also a family man and
enjoyed teaching his sons about sports,
particularly baseball and football. Headrick
is survived by his wife, Barbara; son, John
Andy Headrick Jr. (Jami); grandchildren and
a great grandchild.
Duane C. Hellam, MD 59
Hellam died Friday, July 31, 2015. He was
82. Born in Kittaning, Pa., Hellam later
earned a bachelor’s degree in chemistry with distinction from Arizona State
University. He graduated from Washington
University School of Medicine, cum
laude, was a Jackson Johnson scholar,
a recipient of the Borden Award and
was elected to Alpha Omega Alpha. His
internship and residency were completed
at Barnes Hospital. From 1961–66, he
collaborated in cellular biophysics at the
National Institutes of Health (NIH). From
1966–1975, Hellam worked at Washington
University Diagnostic Center. In 1976, he
joined The Springfield Clinic of Internal
Medicine in Springfield, Mo. Hellam was
an active member in the Greene County
Medical Society and the Missouri State
Medical Association and served on numerous committees at St. John’s Regional
Health Center. He enjoyed many hobbies
but was especially fond of racing cars competitively and playing violin. He is survived
by his wife, Judy; children Todd, Leslie
and Lauraine Ayers-Briel; stepdaughter
Danielle Tuscher; grandchildren; and sister.
Elbert Herman Leigh, MD 61
Leigh died Monday, May 4, 2015. He was
83. Leigh was born in Bolivar, Mo., and
grew up in Warrensburg, Mo., where he
met and married his high school sweetheart, Lucile. Before attending medical
school, Leigh served in the U.S. Air Force
during the Korean War. He earned a
bachelor’s degree from Central Missouri
State College and a medical degree from
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Washington University. Leigh was boardcertified in family medicine, psychiatry
and child and adolescent psychiatry.
Along with being a practicing physician
in these fields, he also was a professor
and was a charter fellow of the American
Academy of Family Medicine. Leigh had a
passion for the outdoors, carpentry, woodworking and playing and building classical
guitars. He is survived by his wife of 64
years, Lucile; their children, Steven (Leah),
Vicki (Peter Muller) and Jason (Paige); and
grandchildren.
Brian T. Lew, MD 82
Lew died June 25, 2015. He was 57. Lew was
an interventional cardiologist at Fairview
Southdale Hospital and North Memorial
Medical Center. After earning a medical
degree at Washington University, Lew completed a residency and fellowship at the
University of Minnesota. He is survived by
his wife, Sheron; sons, Michael and Brandon;
siblings; and nieces and nephews.
Albert P. Scheiner, MD 53, LA 49
Scheiner died Thursday, July 9, 2015. He
was 87. Referred to by friends as “AP,”
Scheiner earned an undergraduate degree
from Washington University, Phi Beta
Kappa. He graduated from the School
of Medicine in 1953 before beginning
a pediatric internship at the University
of Rochester School of Medicine and
Dentistry’s Strong Memorial Hospital.
From 1955-1957, he was a captain in the
U.S. Air Force, serving as a pediatrician,
and afterward returned to Rochester as
chief resident in pediatrics. He joined the
faculty at University of Massachusetts
Medical School in 1975 where he was professor of pediatrics and chairman of the
Developmental Pediatric Outpatient Clinic.
Scheiner thoroughly enjoyed working
with and teaching students and residents.
He retired at age 85 and spent time painting, sailing, skiing and supporting local
theater. He is survived by his wife, Barbara;
three daughters, Laurie, Cathy and Martha;
and grandchildren.
Joe Robert Smith, MD 55
Smith died Monday, June 22, 2015. He
was 87. Smith served in the U.S. Army
from 1946-48. Afterward, he graduated
from Central Missouri State University
with a major in zoology and minor in
outlook.wustl.edu

chemistry. He attended the University
of Missouri School of Medicine and
Washington University School of Medicine
before serving an internship at Kansas
City General Hospital and a residency in
ophthalmology at Washington University.
Smith entered into practice in Columbia,
Mo. He was a long-time member of the
Downtown Rotary Club, serving on its
board of directors. Smith was a sportsman
and enjoyed hunting and fly-fishing as
well as painting and studying British history. He is survived by his brother, Richard
Smith; daughters, Susan Smith Bell
(James), Margaret Smith Whitmer (Gary)
and Audrey Smith Feuerbacher (James);
grandchildren; and a great granddaughter.
Bruce White, MD 64
White died Wednesday, Sept. 2, 2015. After
attending Beloit College, he graduated
from Washington University School of
Medicine and completed general surgery
training at Jewish Hospital and plastic surgery training at The Ohio State University.
Afterward, White returned to St. Louis and
founded St. Louis Cosmetic Surgery Inc.
In 1967-68, he served in Vietnam, as part
of the U.S. Air Force’s medical health assistance program. In addition to his private
practice, White traveled to Washington,
D.C., annually to lobby on behalf of the
Plastic Surgery Society. He also was an avid
athlete and enjoyed running, swimming,
rowing and weight training. He is remembered by family and friends for creating
beauty in the world and as a talented and
compassionate surgeon. White is survived
by his wife of 49 years, Ellen; children
Daniel (Jennifer Haro), Laura White, MD,
(Bradley Levinson); and brother.

S T U D E N T S
Timothy Blair Burnight
Burnight, 28, a doctoral candidate in the
Program in Physical Therapy, died unexpectedly Sept. 4, 2015, at Barnes-Jewish
Hospital. Burnight was to receive a doctor in physical therapy degree in May
2016. He was passionate about health
and wellness, was the recipient of several
scholarships and was an advocate on
behalf of patients. He worked weekends
as an aide at a local hospital. Burnight

came to Washington University from the
University of Houston, where he earned
a master’s degree in psychology and was
elected to Phi Beta Kappa. During his time
in Houston, he participated in a research
fellowship at MD Anderson Cancer Center.
He earned a bachelor’s degree, magna
cum laude, from Purdue University.
Burnight was born in Evanston, Ill., and
lived in Park Ridge, Ill., before leaving for
college. He is survived by his father, Tom
Alan Burnight; a sister; grandparents; and
several aunts, uncles and cousins. He was
preceded in death by his mother, Judith
Lynn (Mann).
Lisa Cristine Simone
Simone, 25, a doctoral candidate in
the Program in Physical Therapy, died
unexpectedly Sept. 29, 2015, in St. Louis.
Simone, who was to receive a doctor of
physical therapy (DPT) degree in May
2016, took her life. Simone loved music
and played several instruments; the cello
was her favorite. Her greatest passion,
however, was dance. She began dance
lessons at age 3, trained for many years at
the Saint Louis Ballet School and eventually performed with the company. Her
love of dance also led to her career choice.
She was inspired to become a physical
therapist after suffering a serious dance
injury and being treated by Lynnette
Khoo-Summers, DPT, an associate professor of physical therapy at Washington
University. The ability to isolate and understand movement fascinated her, and she
was thrilled when she was accepted into
the university’s physical therapy program.
During graduate school, she was especially
dedicated to working with patients with
neurological problems. A St. Louis-area
native, she earned a bachelor’s degree in
biological sciences, summa cum laude,
from the Missouri University of Science
and Technology in Rolla. She is survived
by her parents, Tom and Tina Simone; her
brother, Nick; and her grandparents.
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Shirley Ann Sahrmann, PT, PhD
Professor emeritus of physical therapy,
of neurology and of cell biology & physiology

Where did you go to high school?
Nerinx Hall High School, where I won the senior
award for excellence in athletics and academics. In
those days, even at 5’4” you could play basketball!

Why physical therapy?
I wanted to help children who were paralyzed
due to polio. For somebody who was as active as
I was it was hard to imagine people who couldn’t
participate in athletics, or couldn’t even walk.

Favorite honor:
The Mary McMillan Award. It is the highest honor
from the American Physical Therapy Association.

How does a movement expert stay active?
Walking four to five miles a day with my dog,
Louise, a Louisiana Catahoula Leopard Hound.

I support the School of Medicine because:
I couldn’t imagine a better place, where mentors,
colleagues and students set wonderful examples.
That’s why I put off retirement for so long!

What’s your legacy?
The Movement Science Program, which I developed
and directed, has increased the pool of academic
researchers whose work infuses this field with
new knowledge of human movement.
Like Dr. Sahrmann, consider supporting
Washington University School of Medicine
through an estate gift, life income plan or
other planned gift. For more information, visit
plannedgiving.wustl.edu or call 800.835.3503.
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Consult with your legal or tax adviser
before making a charitable gift.

Shirley Ann
Sahrmann, PT, PhD,
and Louise
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Agar art

Five Petri dishes recently sprouted a masterpiece.
The canvas was a special type of agar — the clear,
jelly-like substrate of microbiology experiments —
which produces various colors when exposed to
bacterial enzymes. Research lab supervisor Melanie
Sullivan applied bacterial “paints” to the agar to recreate Vincent van Gogh’s “Starry Night.” The piece was
submitted to the American Society for Microbiology’s
2015 agar art contest. Sullivan works in the lab of
Stephanie A. Fritz, MD, whose group studies organisms
involved in pediatric infectious diseases.

Proteus mirabilis

Acinetobacter baumannii

Enterococcus faecalis

Klebsiella pneumoniae

A bacterium known for its
swarming motility that is
a common cause of urinary
tract infections

An often drug-resistant
bacterium that is found in
hospital environments and
affects people with weakened
immune systems

A gastrointestinal tract
bacterium that often causes
urinary tract and more severe
infections, particularly in
hospital environments

A bacterium normally found
in the mouth, skin and
intestines that may cause
pneumonia, meningitis and
other health-care-associated
infections
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Going up
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Work progresses on the new Mid-Campus Center, the site of a major research effort
to study construction risks and develop guidelines that could have wide impact on the health of U.S. builders.
Below, proper harnessing reduces fall risk, but the workers’ repeated wrapping and tying of wires around
rebar could lead to musculoskeletal injury. See the story on page 16.
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